Clinical Trial Update: Phase I/II Study of Capecitabine Plus Aflibercept to Treat Metastatic Colorectal Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase I/II trial evaluating capecitabine plus aflibercept in metastatic colorectal cancer has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Aflibercept (Aflibercept)
• Capecitabine (capecitabine)

Snippet

Sponsor: John Strickler, M.D. | Conditions: Metastatic Colorectal Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2017-07-11